SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 86 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2014. The put-call ratio across all filers is 1.76 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $0 | – | 400 | 0.0% | 0.00% | – |
Q4 2015 | $0 | -100.0% | 400 | 0.0% | 0.00% | – |
Q3 2015 | $1,000 | 0.0% | 400 | 0.0% | 0.00% | – |
Q2 2015 | $1,000 | 0.0% | 400 | 0.0% | 0.00% | – |
Q1 2015 | $1,000 | 0.0% | 400 | 0.0% | 0.00% | – |
Q4 2014 | $1,000 | -80.0% | 400 | -68.0% | 0.00% | – |
Q2 2014 | $5,000 | -73.7% | 1,250 | -58.3% | 0.00% | – |
Q3 2013 | $19,000 | – | 3,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 28,639,349 | $123,436,000 | 94.21% |
Verity Asset Management, Inc. | 103,021 | $456,000 | 0.47% |
NBW CAPITAL LLC | 242,153 | $1,044,000 | 0.27% |
Old West Investment Management, LLC | 69,997 | $301,000 | 0.19% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 196,639 | $848,000 | 0.12% |
SOPHROSYNE CAPITAL LLC | 25,700 | $111,000 | 0.10% |
Cutler Capital Management, LLC | 45,000 | $194,000 | 0.08% |
Rotella Capital Management, Inc. | 11,700 | $50,000 | 0.06% |
STONERIDGE INVESTMENT PARTNERS LLC | 66,397 | $286,000 | 0.06% |
Roundview Capital LLC | 21,100 | $91,000 | 0.04% |